Document is current

Any future updates will be listed below

Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain

Crossref DOI link: https://doi.org/10.1186/2050-6511-15-52

Published Online: 2014-09-24

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark